Not all GLP-1 medications are the same As of April 2026, the most popular GLP-1 medications approved by the Food and Drug Administration include semaglutide, sold under the brand names Wegovy, Ozempic and Rybelsus
They are prepared by state-licensed compounding pharmacies under sections 503A and 503B of the FD&C Act
Phentermine is an appetite suppressant ideal for patients who need a rapid early boost or prefer a non-injectable option
In the 2024 guidelines published by the ESC for PAD management, the authors do not mention GLP-1 RAs as part of management, likely due to limited data at the time [50]
The cost of insulin syringes is small compared to ruining a peptide vial
Doctors typically recommend diabetic meds for weight loss to adults with a BMI of 30 or higher, or 27 and above with conditions like high blood pressure, cholesterol issues, or sleep apnea